Canadian Natural Resources is upgraded to Strong Buy as Q3 record output and Asian demand via TMX boost prospects. Click for ...
M&A Call December 8, 2025 10:00 AM ESTCompany ParticipantsDavid Sproule - Senior EVP, CFO & DirectorZack Arnold ...
Before entering 2026, students must focus on goal-setting, time management, digital learning, exam preparation, skill ...
Poster highlights 6-month follow-up data from the ongoing Phase 2 trial of NDV-01 in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety ...
Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.
A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's ...
The MarketWatch News Department was not involved in the creation of this content.-- Phase 3 CDKL5 deficiency disorder (CDD) results: UCB shares 21 scientific abstracts, including ...
Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...
Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci’s ...
Rusfertide was generally well-tolerated through 52 Weeks of treatment. The most common treatment-emergent adverse events (AE) in rusfertide-treated patients were injection site reactions (47.4%), ...
The city’s next mayor, who will be sworn in Wednesday evening, is known for preparation, equity-focused leadership and a ...